Document ID: chunk:federal_register_of_legislation:F2024C01094:front:0:p2
Version: federal_register_of_legislation:F2024C01094
Segment Type: other
Provision Reference: 
Character Range: 2748–4238

3—Payment for special arrangement supplies of designated pharmaceutical benefits
17 Supplies by approved hospital authorities to certain patients
18 Supplies by approved hospital authorities to persons who are not patients
19 Supplies by approved medical practitioners and approved pharmacists
20 Claims for payment by approved suppliers
21 Supplies to authorised alternative suppliers
22 Secretary to determine and pay claims
Division 4—Administration
23 Secretary may request information from authorised alternative suppliers
24 Authorised alternative suppliers to supply information on request
25 Secretary may authorise persons to perform functions or exercise powers
26 Review by Secretary of decisions of persons authorised under section 25
Part 3—Application, saving and transitional provisions
27 Saving of authorisations—National Health (Take Home Naloxone Pilot) Special Arrangement Amendment (2020 Measures No. 1) Instrument 2020
28 Application of amendments—National Health (Take Home Naloxone Pilot) Special Arrangement Amendment (2021 Measures No. 1) Instrument 2021
29 Application of amendments—National Health (Take Home Naloxone Pilot) Special Arrangement Amendment (2022 Measures No. 1) Instrument 2022
Schedule 1—Designated pharmaceutical benefits and maximum quantities or numbers of units
1 Designated pharmaceutical benefits
Endnotes
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history

Part 1—Preliminary